Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1995* | 2020 |
The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1488 | 2018 |
Bone marrow-derived macrophages (BMM): isolation and applications J Weischenfeldt, B Porse Cold Spring Harbor Protocols 2008 (12), pdb. prot5080, 2008 | 1092 | 2008 |
The whole-genome landscape of medulloblastoma subtypes PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ... Nature 547 (7663), 311-317, 2017 | 1075 | 2017 |
Dissecting the genomic complexity underlying medulloblastoma DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ... Nature 488 (7409), 100-105, 2012 | 988 | 2012 |
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations T Rausch, DTW Jones, M Zapatka, AM Stütz, T Zichner, J Weischenfeldt, ... Cell 148 (1), 59-71, 2012 | 979 | 2012 |
Patterns of somatic structural variation in human cancer genomes Y Li, ND Roberts, JA Wala, O Shapira, SE Schumacher, K Kumar, ... Nature 578 (7793), 112-121, 2020 | 815 | 2020 |
Phenotypic impact of genomic structural variation: insights from and for human disease J Weischenfeldt, O Symmons, F Spitz, JO Korbel Nature Reviews Genetics 14 (2), 125-138, 2013 | 716 | 2013 |
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature genetics 52 (3), 331-341, 2020 | 639 | 2020 |
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 583 | 2020 |
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking J Weischenfeldt, T Dubash, AP Drainas, BR Mardin, Y Chen, AM Stütz, ... Nature genetics 49 (1), 65-74, 2017 | 413 | 2017 |
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer J Weischenfeldt, R Simon, L Feuerbach, K Schlangen, D Weichenhan, ... Cancer cell 23 (2), 159-170, 2013 | 401 | 2013 |
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ... The Lancet Oncology 19 (6), 785-798, 2018 | 393 | 2018 |
SvABA: genome-wide detection of structural variants and indels by local assembly JA Wala, P Bandopadhayay, NF Greenwald, R O'Rourke, T Sharpe, ... Genome research 28 (4), 581-591, 2018 | 387 | 2018 |
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ... Nature genetics 52 (3), 306-319, 2020 | 385 | 2020 |
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency M Kovac, C Blattmann, S Ribi, J Smida, NS Mueller, F Engert, ... Nature communications 6 (1), 8940, 2015 | 334 | 2015 |
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements J Weischenfeldt, I Damgaard, D Bryder, K Theilgaard-Mönch, LA Thoren, ... Genes & development 22 (10), 1381-1396, 2008 | 307 | 2008 |
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer D Brocks, Y Assenov, S Minner, O Bogatyrova, R Simon, C Koop, ... Cell reports 8 (3), 798-806, 2014 | 284 | 2014 |
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ... Cancer cell 34 (6), 996-1011. e8, 2018 | 266 | 2018 |
A cell‐based model system links chromothripsis with hyperploidy BR Mardin, AP Drainas, SM Waszak, J Weischenfeldt, M Isokane, ... Molecular systems biology 11 (9), 828, 2015 | 152 | 2015 |